secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K/A
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001193125-26-114764
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharma patent trial delayed to May 18, 2026 in NJ district court
-------------------------------------------------------------------------

- District Court of NJ delayed bench trial between Catalyst and Hetero USA from Mar 23 to May 18, 2026.
- Trial concerns validity of Orange Book-listed patents for FIRDAPSE expiring in 2032, 2034, and 2037.
- The trial is a bench trial (judge only) and will be held in the District of New Jersey.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526114764/0001193125-26-114764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526114764/d25173d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-114764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer